Thus, IL-13Rα2 represents a promising therapeutic target for ACC and other solid malignancies such as pancreatic adenocarcinoma and hepatocellular carcinoma 14,15. The gene discussed is IL13RA2; the disease is adrenal cortex carcinoma.